ASCP CG vs MB: Which Certification Should You Pursue in 2026?
Published 2026-04-27
ASCP CG vs MB: Which Certification Should You Pursue?
Both ASCP CG (Technologist in Cytogenetics) and ASCP MB (Technologist in Molecular Biology) are highly respected lab certifications — and there's real overlap between the disciplines, especially as cytogenetics increasingly relies on molecular techniques like chromosomal microarray and NGS. So which one should you sit for? This guide gives you a direct, head-to-head comparison so you can pick with confidence.
Already leaning CG? Take our free 20-question ASCP CG Initial Assessment to gauge your readiness in 20 minutes.
TL;DR — The 30-Second Answer
| You should pick CG if… | You should pick MB if… |
|---|---|
| You enjoy microscope work and visual pattern recognition | You prefer pipetting, PCR, and bench protocols |
| You want a specialized, less-saturated field | You want broader job options across many lab types |
| You're already in or near a cytogenetics lab | You're in microbiology, virology, or molecular path |
| You want higher median pay in a niche role | You want more open positions nationwide |
| You like clinical genetics and prenatal/oncology cases | You like infectious disease, oncology, and pharmacogenomics |
Side-by-Side Comparison
| Factor | ASCP CG | ASCP MB |
|---|---|---|
| Full name | Technologist in Cytogenetics | Technologist in Molecular Biology |
| Exam length | 100 questions, 2.5 hours, CAT format | 100 questions, 2.5 hours, CAT format |
| Application fee (US, 2026) | $260 | $260 |
| Retake fee | $215 | $215 |
| First-attempt pass rate | ~70–78% | ~72–80% |
| Number of US-certified techs | ~3,500 | ~13,000 |
| Open postings (2026 estimate) | ~600–900 active | ~3,000–4,500 active |
| Median salary (certified, mid-career) | $82,000 | $76,000 |
| Top-quartile salary | $94,000+ | $88,000+ |
| Geographic flexibility | Lower (concentrated in major metros) | Higher (most cities have positions) |
Both exams use the same Computer Adaptive Testing (CAT) format, the same testing centers (Pearson VUE), and identical eligibility-route philosophy. The differences come down to content, work style, and career trajectory.
Content Coverage: What's on Each Exam
ASCP CG covers:
- Chromosome structure, banding, and karyotyping
- ISCN cytogenomic nomenclature
- Constitutional cytogenetics (trisomies, sex chromosome disorders, microdeletions)
- Cancer cytogenetics (CML, AML, ALL, lymphomas)
- Fluorescence in situ hybridization (FISH) — probe types, signal interpretation
- Cell culture, harvesting, and slide preparation
- Quality assurance specific to cytogenetics labs
ASCP MB covers:
- Nucleic acid isolation and quantification
- PCR, qPCR, dPCR, and reverse transcription
- Sanger sequencing and next-generation sequencing (NGS)
- Hybridization-based assays (Southern, Northern, microarray)
- Infectious disease molecular diagnostics
- Inherited disorders and pharmacogenomics
- Oncology molecular markers (BRAF, EGFR, KRAS, BCR-ABL)
There's roughly 15–20% topical overlap — primarily in oncology testing (BCR-ABL, FISH for HER2, microarray) and in QA/QC fundamentals.
Day-to-Day Work: What Will You Actually Do?
A typical CG day:
- Set up cell cultures and harvest metaphases
- Stain and band slides (G-banding, sometimes Q or R)
- Capture images and visually analyze 20+ metaphases per case under a microscope or imaging station
- Identify and karyotype abnormalities, write up ISCN findings
- Set up FISH probes for prenatal, hematology, and solid tumor cases
If you love pattern recognition, microscopy, and careful visual work, CG is rewarding. If staring at chromosomes for hours sounds tedious, you'll burn out fast.
A typical MB day:
- Receive specimens (blood, swabs, tissue, FFPE blocks)
- Extract nucleic acids on automated platforms
- Set up PCR, qPCR, or NGS library prep runs
- Monitor instruments, troubleshoot failed runs, validate results
- Interpret variants against curated databases
If you love bench protocols, automation, and crisp digital outputs, MB is satisfying. If you don't enjoy pipetting or troubleshooting reagent issues, MB will frustrate you.
Career Trajectory & Earning Potential
CG career path
The cytogenetics field is specialized and niche, which means:
- Pros: less salary compression, easier to become "the FISH expert" or "the cancer cyto specialist," strong leverage for raises once you're certified
- Cons: fewer total openings, geographically concentrated in academic medical centers and major reference labs (LabCorp, Quest, Mayo, ARUP)
A motivated CG tech can hit Lead Tech ($95k+) in 5–7 years and Supervisor (15k+) in 8–10 years.
MB career path
Molecular biology is broad and growing fast thanks to NGS, liquid biopsy, and infectious disease panels:
- Pros: roles in nearly every clinical lab, biotech, pharma, and public health, easier to relocate, strong pivot into bioinformatics
- Cons: more salary compression at entry/mid level due to higher supply, faster technology turnover requires constant retraining
MB techs can pivot into bioinformatics ($95k+), clinical applications specialist (05k+) at a vendor, or NGS lab supervisor (10k+) roles.
Which Is Harder?
Honestly? They're comparable in difficulty — both have ~70–80% first-attempt pass rates, both are CAT format with similar question counts. The "harder" one is whichever is further from your current background.
- Coming from a general MLS/MLT role? MB will feel more familiar (you've done PCR, you know QA/QC). CG will require more new vocabulary (banding, ISCN nomenclature, FISH).
- Coming from a research genetics background? CG will leverage your chromosome biology knowledge. MB will feel like sequencing techniques you may not have used clinically.
- Coming from infectious disease micro? MB is the natural progression. CG is a bigger leap.
Can You Get Both?
Yes, and many senior techs do — but don't sit for both at once. The recommended path:
- Pick the certification most relevant to your current job first
- Spend 12–18 months building real bench experience under that credential
- Then sit for the second exam (you'll qualify under the experience route)
Holding both CG + MB typically adds $8,000–5,000/yr to your earning ceiling, especially in molecular cytogenetics roles that require chromosomal microarray + FISH + NGS skills.
Bottom Line
- Pick CG if you're drawn to clinical genetics, microscopy, and visual case work — and you're okay with a more specialized job market.
- Pick MB if you want maximum geographic flexibility, broader career options, and you enjoy bench protocols and automation.
- Pick both (eventually) if you want to be one of the most valuable techs in any cytogenomics or precision oncology lab in the country.
Whichever you choose, the single highest-ROI move is passing on the first attempt. A retake costs $215 plus 6 months of delayed certified-rate pay.
Free Resources to Get Started
- Free 20-question ASCP CG Initial Assessment — your CG readiness in 20 min
- Complete ASCP CG Study Guide — 8–12 week roadmap
- Cytogenetic Technologist Salary 2026 — state-by-state pay
- Top Chromosomal Abnormalities to Know
- FISH Probe Types Explained
Comparison data compiled from ASCP Board of Certification annual reports, BLS Occupational Employment Statistics (May 2025), and 2026 salary data from active job postings on Indeed, LinkedIn, and ASCP Career Center.